# Effects of Delta-9-THC and Iomazenil in Healthy Humans

> **NCT00982982** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 17 (actual)

## Conditions studied

- Schizophrenia
- Mental Disorders
- Psychotic Disorders

## Interventions

- **DRUG:** THC and Iomazenil
- **DRUG:** Placebo (control)

## Key facts

- **NCT ID:** NCT00982982
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-11
- **Primary completion:** 2013-02-22
- **Final completion:** 2013-02-22
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982982, "Effects of Delta-9-THC and Iomazenil in Healthy Humans". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00982982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*